JOYA CHANDRA to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications JOYA CHANDRA has written about Xenograft Model Antitumor Assays.
Connection Strength
0.090
-
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol. 2015 Nov; 17(11):1463-73.
Score: 0.067
-
Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Mol Cancer Ther. 2019 09; 18(9):1615-1627.
Score: 0.023